Premier Inc. reported fiscal fourth-quarter results that exceeded Wall Street expectations. Non-GAAP earnings rose to $0.46 a share, beating the consensus estimate by $0.12, while revenue grew 2% from a year earlier to $257.97 million, about $10 million above analysts’ forecasts. Despite the beat, the health-care improvement company’s stock slipped 1.8% in pre-market trading on 19 August. Analysts offered mixed reactions: Leerink raised its price target to $26 from $24 and maintained a Market Perform rating, whereas Bank of America lifted its target to $21 from $19 but kept an Underperform stance.